{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:02:40Z","timestamp":1758672160755,"version":"3.44.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3124,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.virol.2004.11.012","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T00:30:23Z","timestamp":1103157023000},"page":"258-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection"],"prefix":"10.1016","volume":"332","author":[{"given":"Elena I.","family":"Marusich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahida","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Strayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph C.","family":"Dornburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger J.","family":"Pomerantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.virol.2004.11.012_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/088922202753472856","article-title":"Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection","volume":"18","author":"Agostini","year":"2002","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.virol.2004.11.012_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/335395a0","article-title":"Intracellular immunization","volume":"335","author":"Baltimore","year":"1988","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.virol.2004.11.012_bib3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/10430340050015194","article-title":"Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer","volume":"11","author":"Bosch","year":"2000","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.virol.2004.11.012_bib4","first-page":"6","article-title":"Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies","volume":"3","author":"BouHamdan","year":"2000","journal-title":"J. Hum. Virol."},{"issue":"1","key":"10.1016\/j.virol.2004.11.012_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.gt.3300545","article-title":"Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector","volume":"5","author":"Cara","year":"1998","journal-title":"Gene Ther."},{"issue":"5466","key":"10.1016\/j.virol.2004.11.012_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzo-Calvo","year":"2000","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.virol.2004.11.012_bib7","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/jvi.69.4.2659-2663.1995","article-title":"Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer","volume":"69","author":"Chu","year":"1995","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2004.11.012_bib8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1128\/jvi.71.1.720-725.1997","article-title":"Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies","volume":"71","author":"Chu","year":"1997","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2004.11.012_bib9","first-page":"292","article-title":"Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins","volume":"1","author":"Chu","year":"1994","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.virol.2004.11.012_bib10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1084\/jem.170.4.1149","article-title":"Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types","volume":"170","author":"Collman","year":"1989","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.virol.2004.11.012_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/85454","article-title":"In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice","volume":"7","author":"Consiglio","year":"2001","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.virol.2004.11.012_bib12","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1128\/jvi.68.7.4442-4449.1994","article-title":"Functional exchange of an oncoretrovirus and a lentivirus matrix protein","volume":"68","author":"Deminie","year":"1994","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2004.11.012_bib13","first-page":"301","article-title":"Reticuloendotheliosis viruses and derived vectors","volume":"2","author":"Dornburg","year":"1995","journal-title":"Gene Ther."},{"issue":"6","key":"10.1016\/j.virol.2004.11.012_bib14","first-page":"457","article-title":"From the natural evolution to the genetic manipulation of the host-range of retroviruses","volume":"378","author":"Dornburg","year":"1997","journal-title":"Biol. Chem."},{"key":"10.1016\/j.virol.2004.11.012_bib15","first-page":"133","article-title":"Reticuloendotheliousis virus-derived vectors for human gene therapy","volume":"6","author":"Dornburg","year":"2001","journal-title":"Gene Ther. Mol. Biol."},{"issue":"6","key":"10.1016\/j.virol.2004.11.012_bib16","first-page":"2328","article-title":"Retroviral vector system for the study of cDNA gene formation","volume":"8","author":"Dornburg","year":"1988","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.virol.2004.11.012_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.gt.3300422","article-title":"Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy","volume":"4","author":"Duan","year":"1997","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.virol.2004.11.012_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/10430340050016030","article-title":"Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library","volume":"11","author":"Engelstadter","year":"2000","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.virol.2004.11.012_bib19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/JVI.74.1.518-522.2000","article-title":"Avian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells","volume":"74","author":"Gautier","year":"2000","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2004.11.012_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ymthe.2004.01.009","article-title":"Spliced spleen necrosis virus vector RNA is not encapsidated: implications for retroviral replication and vector design","volume":"9","author":"Goodrich","year":"2004","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.virol.2004.11.012_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00204747","article-title":"Development of retroviral vectors as safe, targeted gene delivery systems","volume":"74","author":"Gunzburg","year":"1996","journal-title":"J. Mol. Med."},{"issue":"2\u20133","key":"10.1016\/j.virol.2004.11.012_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0169-409X(00)00093-4","article-title":"Transcriptional control: an essential component of cancer gene therapy strategy?","volume":"44","author":"Harrington","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.virol.2004.11.012_bib23","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1128\/jvi.64.12.6329-6334.1990","article-title":"The U3 region is not necessary for 3\u2032 end formation of spleen necrosis virus RNA","volume":"64","author":"Iwasaki","year":"1990","journal-title":"J. Virol."},{"issue":"5875","key":"10.1016\/j.virol.2004.11.012_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/298623a0","article-title":"De novo methylation and expression of retroviral genomes during mouse embryogenesis","volume":"298","author":"Janhner","year":"1982","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.virol.2004.11.012_bib25","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/sj.gt.3301043","article-title":"In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies","volume":"6","author":"Jiang","year":"1999","journal-title":"Gene Ther."},{"issue":"12","key":"10.1016\/j.virol.2004.11.012_bib26","doi-asserted-by":"crossref","first-page":"10148","DOI":"10.1128\/JVI.72.12.10148-10156.1998","article-title":"Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies","volume":"72","author":"Jiang","year":"1998","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.virol.2004.11.012_bib27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1089\/aid.1997.13.1395","article-title":"Antiviral potency of drug-gene therapy combinations against human immunodeficiency virus type 1","volume":"13","author":"Junker","year":"1997","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"6","key":"10.1016\/j.virol.2004.11.012_bib28","first-page":"1172","article-title":"New procedure for DNA transfection with polycation and dimethyl sulfoxide","volume":"4","author":"Kawai","year":"1984","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.virol.2004.11.012_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0079-6123(00)27016-7","article-title":"Neuropathology of fetal nigra transplants for Parkinson's disease","volume":"127","author":"Kordower","year":"2000","journal-title":"Prog. Brain Res."},{"issue":"12","key":"10.1016\/j.virol.2004.11.012_bib30","doi-asserted-by":"crossref","first-page":"8821","DOI":"10.1128\/jvi.70.12.8821-8832.1996","article-title":"Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase","volume":"70","author":"Levy-Mintz","year":"1996","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2004.11.012_bib31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/jvi.68.1.510-516.1994","article-title":"Passage through mitosis is required for oncoretrovirus but not for the human immunodeficiency virus","volume":"68","author":"Lewis","year":"1994","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2004.11.012_bib32","first-page":"32","article-title":"Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells","volume":"1","author":"Liu","year":"1994","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.virol.2004.11.012_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0092-8674(89)90416-9","article-title":"Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function","volume":"58","author":"Malim","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.virol.2004.11.012_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0092-8674(83)90344-6","article-title":"Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus","volume":"33","author":"Mann","year":"1983","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.virol.2004.11.012_bib35","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1089\/hum.1998.9.11-1627","article-title":"Intracellular antibodies against HIV-1 envelope protein for AIDS gene therapy","volume":"9","author":"Marasco","year":"1998","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.virol.2004.11.012_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/10430340050016076","article-title":"Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir","volume":"11","author":"Mukhtar","year":"2000","journal-title":"Hum. Gene Ther."},{"issue":"8","key":"10.1016\/j.virol.2004.11.012_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1371\/journal.pbio.0020234","article-title":"Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences","volume":"2","author":"Mitchell","year":"2004","journal-title":"PLOS Biol."},{"issue":"21","key":"10.1016\/j.virol.2004.11.012_bib38","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1073\/pnas.93.21.11382","article-title":"Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector","volume":"93","author":"Naldini","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5259","key":"10.1016\/j.virol.2004.11.012_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.virol.2004.11.012_bib41","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/76458","article-title":"Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells","volume":"18","author":"Parveen","year":"2000","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.virol.2004.11.012_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0042-6822(03)00402-1","article-title":"Cell-type-specific gene delivery into neuronal cells in vitro and in vivo","volume":"314","author":"Parveen","year":"2003","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virol.2004.11.012_bib43","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nm0703-867","article-title":"Twenty years of therapy for HIV-1 infection","volume":"9","author":"Pomerantz","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2004.11.012_bib44","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1089\/104303400750038499","article-title":"A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciciovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme","volume":"11","author":"Rainov","year":"2000","journal-title":"Hum. Gene Ther."},{"issue":"6","key":"10.1016\/j.virol.2004.11.012_bib45","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1128\/jvi.70.6.3392-3400.1996","article-title":"Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle","volume":"70","author":"Shaheen","year":"1996","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2004.11.012_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.gt.3301371","article-title":"Eradication of murine brain tumors by direct inoculation of concentrated high titer recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene","volume":"8","author":"Tamura","year":"2001","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.virol.2004.11.012_bib47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/mthe.2000.0255","article-title":"Rhesus monkey model for fetal gene transfer: studies with retroviral-based vector system","volume":"3","author":"Tarantal","year":"2001","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.virol.2004.11.012_bib48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev., Genet."},{"issue":"Pt. A","key":"10.1016\/j.virol.2004.11.012_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0091-679X(08)60600-7","article-title":"Generation of high-titer pseudotyped retroviral vectors with very broad host range","volume":"43","author":"Yee","year":"1994","journal-title":"Methods Cell Biol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682204007718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682204007718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:32:42Z","timestamp":1758583962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682204007718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0042682204007718"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2004.11.012","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2004.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}